These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38831745)

  • 1. Xenohormetic Phytochemicals Inhibit Neovascularization in Microphysiological Models of Vasculogenesis and Tumor Angiogenesis.
    Kpeli GW; Conrad KM; Bralower W; Byrne CE; Boue SM; Burow ME; Mondrinos MJ
    Adv Biol (Weinh); 2024 Jul; 8(7):e2300480. PubMed ID: 38831745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of glyceollins on vasculogenesis through suppression of endothelial progenitor cell function.
    Choi JH; Nguyen MP; Jung SY; Kwon SM; Jee JG; Bae JS; Lee S; Lee MY; Lee YM
    Mol Nutr Food Res; 2013 Oct; 57(10):1762-71. PubMed ID: 23784812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Systems Pharmacology Approach Uncovers Wogonoside as an Angiogenesis Inhibitor of Triple-Negative Breast Cancer by Targeting Hedgehog Signaling.
    Huang Y; Fang J; Lu W; Wang Z; Wang Q; Hou Y; Jiang X; Reizes O; Lathia J; Nussinov R; Eng C; Cheng F
    Cell Chem Biol; 2019 Aug; 26(8):1143-1158.e6. PubMed ID: 31178408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naringenin exerts anti-angiogenic effects in human endothelial cells: Involvement of ERRα/VEGF/KDR signaling pathway.
    Li Q; Wang Y; Zhang L; Chen L; Du Y; Ye T; Shi X
    Fitoterapia; 2016 Jun; 111():78-86. PubMed ID: 27105956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Vasculogenic Mimicry and Angiogenesis by an Anti-EGFR IgG1-Human Endostatin-P125A Fusion Protein Reduces Triple Negative Breast Cancer Metastases.
    Shin SU; Cho HM; Das R; Gil-Henn H; Ramakrishnan S; Al Bayati A; Carroll SF; Zhang Y; Sankar AP; Elledge C; Pimentel A; Blonska M; Rosenblatt JD
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem-like tumor cells involved in heterogeneous vasculogenesis in breast cancer.
    Mao Y; Zhu L; Huang Z; Luo C; Zhou T; Li L; Wang G; Yang Z; Qi W; Yang X; Gao G
    Endocr Relat Cancer; 2020 Jan; 27(1):23-39. PubMed ID: 31705798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glyceollins, a novel class of soy phytoalexins, inhibit angiogenesis by blocking the VEGF and bFGF signaling pathways.
    Lee SH; Lee J; Jung MH; Lee YM
    Mol Nutr Food Res; 2013 Feb; 57(2):225-34. PubMed ID: 23229497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals.
    Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H
    Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An isoflavone derivative potently inhibits the angiogenesis and progression of triple-negative breast cancer by targeting the MTA2/SerRS/VEGFA pathway.
    Zhang X; Zou G; Li X; Wang L; Xie T; Zhao J; Wang L; Jiao S; Xiang R; Ye H; Shi Y
    Cancer Biol Med; 2020 Aug; 17(3):693-706. PubMed ID: 32944400
    [No Abstract]   [Full Text] [Related]  

  • 10. Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers.
    Di Mauro C; Rosa R; D'Amato V; Ciciola P; Servetto A; Marciano R; Orsini RC; Formisano L; De Falco S; Cicatiello V; Di Bonito M; Cantile M; Collina F; Chambery A; Veneziani BM; De Placido S; Bianco R
    Br J Cancer; 2017 May; 116(11):1425-1435. PubMed ID: 28441382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The targetable nanoparticle BAF312@cRGD-CaP-NP represses tumor growth and angiogenesis by downregulating the S1PR1/P-STAT3/VEGFA axis in triple-negative breast cancer.
    Gong K; Jiao J; Xu C; Dong Y; Li D; He D; Zhao D; Yu J; Sun Y; Zhang W; Bai M; Duan Y
    J Nanobiotechnology; 2021 May; 19(1):165. PubMed ID: 34059068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The isoflavone metabolite 6-methoxyequol inhibits angiogenesis and suppresses tumor growth.
    Bellou S; Karali E; Bagli E; Al-Maharik N; Morbidelli L; Ziche M; Adlercreutz H; Murphy C; Fotsis T
    Mol Cancer; 2012 May; 11():35. PubMed ID: 22583931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of EZH2 and P65 is involved in the arsenic trioxide-induced anti-angiogenesis in human triple-negative breast cancer cells.
    Jiang F; Li Y; Si L; Zhang Z; Li Z
    Cell Biol Toxicol; 2019 Aug; 35(4):361-371. PubMed ID: 30612216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naringenin exerts anticancer effects by inducing tumor cell death and inhibiting angiogenesis in malignant melanoma.
    Choi J; Lee DH; Jang H; Park SY; Seol JW
    Int J Med Sci; 2020; 17(18):3049-3057. PubMed ID: 33173425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fisetin inhibits various attributes of angiogenesis in vitro and in vivo--implications for angioprevention.
    Bhat TA; Nambiar D; Pal A; Agarwal R; Singh RP
    Carcinogenesis; 2012 Feb; 33(2):385-93. PubMed ID: 22139440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EPAC inhibitor suppresses angiogenesis and tumor growth of triple-negative breast cancer.
    Li Z; Liu Q; Cai Y; Ye N; He Z; Yao Y; Ding Y; Wang P; Qi C; Zheng L; Wang L; Zhou J; Zhang QQ
    Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167114. PubMed ID: 38447883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Angiogenic Effects of Phytochemicals on miRNA Regulating Breast Cancer Progression.
    Varghese E; Liskova A; Kubatka P; Mathews Samuel S; Büsselberg D
    Biomolecules; 2020 Jan; 10(2):. PubMed ID: 32012744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipalmitoylphosphatidic acid inhibits breast cancer growth by suppressing angiogenesis via inhibition of the CUX1/FGF1/HGF signalling pathway.
    Chen J; Zhou Z; Yao Y; Dai J; Zhou D; Wang L; Zhang QQ
    J Cell Mol Med; 2018 Oct; 22(10):4760-4770. PubMed ID: 30010249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model.
    Kim E; Tunset HM; Cebulla J; Vettukattil R; Helgesen H; Feuerherm AJ; Engebråten O; Mælandsmo GM; Johansen B; Moestue SA
    BMC Cancer; 2016 Mar; 16():191. PubMed ID: 26951085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tocilizumab inhibits IL-8 and the proangiogenic potential of triple negative breast cancer cells.
    Alraouji NN; Aboussekhra A
    Mol Carcinog; 2021 Jan; 60(1):51-59. PubMed ID: 33264466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.